LB Pharmaceuticals Inc Common Stock (LBRX) Financials

LBRX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 361.7 million 29.3 million
March 31, 2026 393.5 million 14.8 million
Dec. 31, 2025 312.9 million 11.6 million
Sept. 30, 2025 320.7 million 10.5 million

LBRX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -38.0 million 4.9 million
March 31, 2026 -23.3 million 2.6 million
Dec. 31, 2025 -18.1 million 2.3 million
Sept. 30, 2025 -3.4 million 881000

LBRX Net Income

No data available :(

LBRX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 327.8 million - 5.2 million
March 31, 2026 365.6 million - 2.7 million
Dec. 31, 2025 295.2 million - 2.8 million
Sept. 30, 2025 314.5 million - 2.9 million

LBRX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 30.1 million
March 31, 2026 28.2 million
Dec. 31, 2025 25.3 million
Sept. 30, 2025 25.3 million

LBRX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 363000 44.1 million 9.7 million -
March 31, 2026 32000 14.6 million 7.4 million -
Dec. 31, 2025 40000 8.5 million 5.4 million -
Sept. 30, 2025 - 2.4 million 2.8 million -

LBRX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 97000
March 31, 2026 - 82000
Dec. 31, 2025 - 85000
Sept. 30, 2025 - 81000

LBRX

Price: $47.49

52 week price:
13.36
49.14

Earnings Per Share: -5.10 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 1.5 billion

Links: